BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November

Day

• 2
• 3
• 4
• 5
• 6
• 7

• Press Releases

  Servier Announces Positive Findings from Longer-Term Analysis of the Phase 3 INDIGO Trial Showing Continued Durable Treatment Effect of VORANIGO® (vorasidenib) Published in The Lancet Oncology

  November 4, 2025

   · 

  12 min read
• Press Releases

  Eisai Demonstrates Commitment to Advanced Endometrial Cancer Care at IGCS 2025

  November 4, 2025

   · 

  25 min read
• Press Releases

  INOVIO Completes Rolling BLA Submission Seeking Accelerated Approval for INO-3107 as a Treatment for RRP in Adults

  November 4, 2025

   · 

  8 min read
• Press Releases

  Alcresta Therapeutics Announces FDA Clearance for Expanded Use of RELiZORB® (iMMOBILIZED LIPASE) Cartridge for Neonates and Infants

  November 4, 2025

   · 

  3 min read
• Press Releases

  CREATE Medicines to Present Late-Breaking Clinical Data on MT-302 at the Society for Immunotherapy of Cancer (SITC) 40th Annual Meeting

  November 4, 2025

   · 

  2 min read
• Press Releases

  Advita Ortho Launches to Advance Patient Lives through Orthopedic Innovation

  November 4, 2025

   · 

  6 min read
• Press Releases

  Virax Biolabs Completes UK Clinical Recruitment and Reports Constructive FDA Feedback for ViraxImmune™ Study Evaluating T Cell Dysfunction in Post-Acute Infection Syndromes

  November 4, 2025

   · 

  5 min read
• Press Releases

  Lilly plans to build a new $3 billion facility to boost oral medicine manufacturing capacity in Europe for patients worldwide

  November 4, 2025

   · 

  6 min read
• Press Releases

  Amarin To Present New Analyses Affirming Robustness of Data from REDUCE-IT and Additional Mechanisms of Action of Eicosapentaenoic Acid (EPA) at American Heart Association (AHA) Scientific Sessions 2025

  November 4, 2025

   · 

  8 min read
• Press Releases

  Femasys Secures FDA Approval to Advance Final FemBloc® Trial Phase and $12 Million Financing, with Potential to Reach $58 Million

  November 4, 2025

   · 

  9 min read